Zhang Peng, Wu Xiaofang, Yuan Rui, Yan Wei, Xu Deshun, Ji Lei, Chen Liping
Huzhou Center for Disease Control and Prevention, Huzhou, 313000, China.
Int J Infect Dis. 2022 Sep;122:93-98. doi: 10.1016/j.ijid.2022.05.023. Epub 2022 May 11.
During our surveillance period, we found a new type of Vibrio parahaemolyticus (V. parahaemolyticus) with serotype O10:K4, which had increased over the past 2 years in Huzhou and became the second most common serotype after O3:K6.
Strains were isolated from stool samples of diarrhea patients in the First People's Hospital in Huzhou. The serotypes, virulence-associated genes, antimicrobial susceptibility, and pulsed field gel electrophoresis (PFGE) of these strains were analyzed.
Between January 2017 and December 2021, there were 598 (5.36%) V. parahaemolyticus-positive samples of 11,166 stool specimens. The V. parahaemolyticus detection rate was high in summer months. The O3:K6 was the dominant serotype in 2017-2020 and a new serotype, O10:K4, was the predominant serotype in 2021. The majority of isolates tested were resistant to ampicillin (86.8%). We randomly chose the strains with serotype O3:K6 and O10:K4 for PFGE to compare the genetic relationship between these two serotypes. The results showed that the PFGE profiles of V. parahaemolyticus O3:K6 and O10:K4 were genetically similar. The strains showed a tendency to cluster on the basis of their serotype profiles. However, some O3:K6 strains showed 100% similarity with O10:K4 strains.
A new serotype with pandemic potential of V. parahaemolyticus, O10:K4, was detected in 2020 and became dominant in 2021 in Huzhou.
在我们的监测期间,我们发现了一种新型副溶血性弧菌(副溶血性弧菌),血清型为O10:K4,在湖州过去两年中有所增加,并成为仅次于O3:K6的第二常见血清型。
从湖州市第一人民医院腹泻患者的粪便样本中分离菌株。对这些菌株的血清型、毒力相关基因、抗菌药物敏感性和脉冲场凝胶电泳(PFGE)进行分析。
2017年1月至2021年12月,在11166份粪便标本中有598份(5.36%)副溶血性弧菌阳性样本。副溶血性弧菌在夏季月份的检出率较高。O3:K6是2017 - 2020年的优势血清型,而新血清型O10:K4是2021年的主要血清型。大多数测试分离株对氨苄西林耐药(86.8%)。我们随机选择O3:K6和O10:K4血清型的菌株进行PFGE,以比较这两种血清型之间的遗传关系。结果表明,副溶血性弧菌O3:K6和O10:K4的PFGE图谱在基因上相似。菌株根据其血清型图谱显示出聚类趋势。然而,一些O3:K6菌株与O10:K4菌株显示出100%的相似性。
2020年检测到一种具有大流行潜力的新型副溶血性弧菌血清型O10:K4,并于2021年在湖州成为优势血清型。